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Purpose: This study evaluated and compared changes over time in health-related quality of life reported by patients with
infrarenal abdominal aortic aneurysm (AAA) undergoing elective endovascular (EVAR) and open aneurysm (OR) repair.
Methods: A prospective, nonrandomized cohort of 76 patients (62 men, 14 women; age range, 42 to 89 years) undergoing
elective, infrarenal AAA repair (EVAR, n  43; OR, n  33) at two university teaching hospitals during a 15-month
period were administered the Medical Outcomes Study Short-Form 36-item (SF-36) health survey preoperatively and
then 1 week, 1 month, and 6 months postoperatively. Patient demographics, procedural details, postoperative follow-up
data, and SF-36 scores were compared between groups.
Results: Both groups had total SF-36 scores that were significantly lower than preoperative scores at 1 week and 1 month
after surgery but were not significantly different from the preoperative scores at 6 months (OR 66.2  21.1 to 72.3 
19.8, P > .1; and EVAR 61.0  17.7 to 58.7  19.4, P > .1). Six-month total SF-36 scores were significantly higher in
the OR group compared with the EVAR group (mean 72.3  19.8 OR vs 58.7  19.4 EVAR; P  .009). In the
postoperative period, a significant drop occurred in mean scores in six of the eight domains of the SF-36 in the OR
patients (physical function, PF; role physical, RP; bodily pain, BP; vitality, VT; social function, SF; role emotional, RE)
and five domains for EVAR patients (PF, RP, BP, SF, RE). In two domains, RE and PF, scores returned to baseline values
significantly sooner in EVAR patients than in OR patients (RE, EVAR 1month vs OR 6months; and PF, EVAR 1month
vs OR 6 months). In the VT domain, no significant postoperative drop occurred in the EVAR group, but in the OR
group, mean scores were significantly lower at 1 week and 1 month compared with preoperative values. In the domains
of general health and mental health, no significant drop occurred in SF-36 score postoperatively in either group.
Conclusions: Patient reported health-related quality of life after infrarenal AAA repair is significantly impaired in the early
postoperative period but returns to baseline by 6 months in patients treated with EVAR and OR. Patients having EVAR
had significantly more rapid return to preoperative scores in selected domains of the SF-36. Even though EVAR is
associated with shorter and less invasive perioperative hospital course and fewer postoperative complications, EVAR
patients had lower quality of life scores 6 months after surgery than OR patients. ( J Vasc Surg 2006;44:1182-7.)Endovascular techniques have developed rapidly within
the last 15 years, and as a result, endovascular aneurysm
repair (EVAR) has developed as a viable noninvasive option
for the treatment of patients with elective aneurysms.1,2
Compared with the wealth of published information eval-
uating medical and technical outcomes, studies that evalu-
ate outcome from a patient’s perspective are relatively rare.
Studies measuring patient-perceived quality of life after
conventional open aneurysm repair demonstrate stable or
even improved quality of life scores after the postoperative
recovery period.3-5 Although EVAR is a less invasive pro-
cedure and it therefore should intuitively have less negative
impact on patient quality of life in the early recovery period,
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1182it is not clear what other factors, such as the need for
long-term follow-up and the need for secondary interven-
tions, will have on patient-reported quality of life. Only a
few published reports have compared patient-perceived
quality of life after endovascular and open surgery for
abdominal aortic aneurysm (AAA), and the results of these
studies are not consistent.6-9
In this prospective non-randomized study, we used a
validated measurement tool, the Medical Outcomes Study
Short-Form 36-item (SF-36) (Medical Outcomes Trust,
Inc, Boston, Mass), to compare the changes over time in
patient-perceived quality of life during 6 months after
elective EVAR and open repair (OR) for AAAs.
METHODS
During a period of 15 months, we conducted a prospec-
tive nonrandomized study to compare patient-perceived
quality of life in patients after elective infrarenal AAA repair
at two hospital sites associated with McGill University.
Both centers are tertiary care referral sites for vascular
surgery and both routinely perform both OR and EVAR for
infrarenal AAAs. During the study period, EVAR was se-
lected for patients with suitable anatomy who were consid-
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was performed using a transperitoneal approach in all cases.
The Institutional Review Board Ethics Committees
granted approval for this study for each site. All patients of
surgeons who routinely perform both OR and EVAR of
AAA were eligible for recruitment. Patients were excluded
from the study if the treating surgeon did not perform
EVAR, if the patient did not speak English or French, was
unable to understand the quality of life questionnaire pro-
vided in this study, had follow-up in another institution,
refused to participate, or if the procedure was performed to
treat a symptomatic or ruptured AAA. During the study
period, 66 patients with AAAs had elective EVAR and 121
patients had elective OR. Of those, 43 EVAR and 33 OR
patients were recruited into the study. Recruitment of pa-
tients was in a nonconsecutive fashion.
After patients gave informed consent to participate in
the study, they were interviewed by a vascular resident or
research nurse before treatment. Functional status along
with demographic data and cardiovascular risk factors were
recorded. Procedural data and in-hospital outcome data
were recorded in both groups, including mortality, mor-
bidity, postoperative analgesia, time to resumption of oral
intake, duration of urinary catheterization, time to full
ambulation, intensive care unit stay, and postoperative
length of stay.
Health-related quality of life (HRQOL) was assessed
with the SF-36.10 The SF-36 is a generic HRQOL mea-
surement tool that can be reliably self-administered by an
elderly population. It consists of 36 questions that are used
to define eight health concepts or domains: physical func-
tion (PF), role physical (RP), bodily pain (BP), general
health (GH), vitality (VT), social function (SF), mental
health (MH), and role emotional (RE). Two summary
scales, physical health summary (PHS) and mental health
summary (MHS), are derived from the eight health do-
mains. For each domain, a raw score is transformed from
0 (worst health) to 100 (best health scale). The French and
English version of the questionnaire was available accord-
ing to the patient’s preference.
The SF-36 was self-administered 1 week preopera-
tively to all EVAR and OR patients. It was then self-
administered again in the postoperative period at 1 week,
1 month, and at 6 months. SF-36 scores were computed
using commercially available software (SF-36 Outcomes,
IMF Consultants, Sharon, Ontario, Canada). Statistical
analysis was completed with the NCSS97desktop software
package (Number Cruncher Statistical System, Dr. JL
Hintze, Kaysville, UT). Categoric variables were compared
with 2 statistics. Continuous variables and individual
HRQOL scores were compared by t test.
RESULTS
Preoperative baseline patient characteristics. During
the 15 months of the study, 76 patients were recruited (43
EVAR and 33 OR) (Table I). The EVAR patients were
significantly older than the OR cohort (mean, 76.1 years vs
68.6 years, P  .002). Preoperative functional status wassimilar in both groups, except that 15% of OR group were
still working at the time of treatment. There was no signif-
icant difference in the prevalence of preoperative cardiovas-
cular risk factors or American Society of Anesthesiologist
class between the two groups. A history of cancer was
significantly more common in the EVAR group (EVAR,
30.2% vs OR, 6.1%; P  .009). The mean preoperative
baseline total HRQOL SF-36 scores between the two
groups were not significantly different (66.2 21.1 OR vs
61.0  17.7 EVAR, P  .283).
Intraoperative course and postoperative outcomes.
All OR procedures were preformed under general anesthe-
sia, and almost all of the EVAR procedures (95.3%) were
performed under regional anesthesia. The operative time
did not differ between the two groups. However, the OR
group had significantly higher mean intraoperative blood
loss (300  219 mL vs 1200  1270 mL; P  .001),
autotransfusion (0 vs 81.1% patients, 0 vs 652 598.8 mL;
P  .001), and number of patients requiring banked
blood transfusion (6.9% vs 27.3%; P  .025, 2).
Significant differences were noted in the in-hospital
recovery between the EVAR and the OR groups (Table II).
No patients in either group died in-hospital or periopera-
Table I. Comparison of patient demographics between
endovascular and open repair patients
EVAR
(n  43)
Open
(n  33) P
Gender (% male) 86.1 75.8 NS
Mean age  SD 76.1  7.3 68.6  9.4 .002
Preoperative functional
status (%)
Activities of daily living
Self-dependent 88.3 97 NS
Depends on family 9.3 3 NS
Depends on nursing home 2.3 0 NS
Walks with aid 14 12.1 NS
Going to work 0 15.1 .008
Preoperative risk factors (%)
Ischemic heart disease 67.4 66.7 NS
History of MI 46.5 42.4 NS
Aortocoronary bypass 23.3 15.1 NS
Arrhythmias 18.6 24.2 NS
Diabetes mellitus 11.6 21.2 NS
Hypertension 62.8 57.6 NS
Hyperlipidemia 44.2 45.4 NS
COPD 34.9 21.2 NS
Renal failure* 11.6 3 NS
Stroke 13.9 9.1 NS
PVD 16.3 24.2 NS
History of cancer 30.2 6.1 .009
Smoking (mean pack/
year  SD) 46  11.8 50  20.7 NS
Preoperative total SF-36
scores (SD) 61.0 (17.7) 66.2 (21.1) NS
EVAR, Endovascular aneurysm repair; SD, standard deviation; MI, myocar-
dial infarction; COPD, chronic obstructive pulmonary disease; PVD, periph-
eral vascular disease; SF-36, Medical Outcomes Study Short-Form 36-item
health survey.
*Serum creatinine 110 mol/L.tively (30-day postsurgery); however, three EVAR patients
s narco
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nia and 2 and 5 months postsurgery of myocardial infarc-
tion). The overall perioperative complication rate was sig-
nificantly higher in the OR patients (57.6% vs 30.2%, P 
.017).
The need for reoperation or reintervention in the initial
admission was not significantly different between the two
groups: five patients in EVAR (graft limb thrombosis in 3,
and one patient each with distal arterial embolization and
endoleak) vs two patients in OR (graft limb thrombosis in 1
and wound dehiscence in 1; PNS). EVAR patients were
readmitted to hospital for vascular and non-vascular-related
problems significantly more often 6 months of surgery
(EVAR, 25.6% vs OR, 6.1%; P  .025).
SF-36 results. No significant difference was noted in
mean preoperative baseline total HRQOL SF-36 scores
between the two groups (66.2  21.1 OR vs 61.0  17.7
EVAR, P  .283). During the early postoperative period,
SF-36 total scores were significantly lower than the baseline
scores at 1 week and 1 month in both OR and EVAR
patients. Compared with preoperative scores, no signif-
icant difference was found in mean 6 month SF-36 total
scores in either group (66.2  21.1 to 72.3  19.8 OR,
P  .1; 61.0  17.7 to 58.7  19.4 EVAR, P  .1).
Although mean preoperative total SF-36 scores between
OR and EVAR patients were not significantly different,
the mean SF-36 scores for OR patients at 6 months were
significantly higher than for EVAR patients (72.3  19.8
OR vs 58.7  19.4 EVAR, P  .009) (Table III).
The scores within individual domains of the SF-36
(Fig 1 and Table IV), show a postoperative drop occurred
in six of the eight domains after surgery for OR patients
(physical function, PF; role physical, RP; bodily pain, BP;
vitality, VT; social function, SF; role emotional, RE) and in
five domains for EVAR patients (PF, RP, BP, SF, RE). In
the RE and PF domains of the SF-36, scores returned to
baseline values significantly sooner in EVAR patients than
in OR patients (RE, EVAR 1 month vs OR 6 months; and
PF, EVAR 1 month vs OR 6 months). In the domain of
vitality, there was no significant postoperative drop in the
EVAR group, but in the OR group, scores were signifi-
cantly lower at 1 week and 1 month compared with preop-
Table II. Comparison of postoperative in-hospital course
Postoperative analgesia use
Epidural, n (%)
PCA, n (%)
Nasogastric tube required, n (%)
Median hours to full diet (mean  SD)
Patients with ileus 2days, n (%)
Median hours urinary cath (mean  SD)
Median hours to unassisted ambulation (mean  SD)
ICU monitoring, n (%)
Median post-op hospital stay, days (mean  SD)
EVAR, Endovascular aneurysm repair; PCA, patient-controlled intravenouerative values. In the domains of general health and mentalhealth, no significant drop occurred in the SF-36 score
postoperatively in either group.
Because the univariate analysis of baseline characteris-
tics showed that the mean age of patients in the EVAR
group was significantly older (mean, 76.1 years vs 68.6
years, P  .02), we repeated the analysis of the SF-36 data
with age-adjusted values. Analysis of age-adjusted SF-36
scores showed that EVAR patients had significantly lower
mean scores within the domains of general health and
vitality preoperatively. This age-adjusted analysis did not
significantly change the postoperative outcomes (Tables III
and IV). Furthermore, repeat analysis excluding patients
who were readmitted to hospital after the initial hospital-
ization or excluding patients requiring reoperation did not
change any of the outcomes.
DISCUSSION
The management of infrarenal AAAs has changed in
een endovascular and open repair patients
AR (n  43) Open (n  33) P
.001
4) 18 (54.5)
) 8 (24.2)
.3) 33 (100) .001
9.6  30.8) 96 (123.3  75.5) .001
.7) 7 (21.2) .027
2.7  85) 72 (93.1  54.7) .033
9.7  132.2) 96 (136.9  86.9) .011
8.6) 33 (100) .001
.9  8.3) 7 (10.3  7.5) .019
tic analgesia; ICU, intensive care unit.
Table III. Comparison of crude and age-adjusted SF-36
mean scores between open and endovascular repair
groups at preoperative and each of three follow-up time
intervals
Procedure
P*Open Endovascular
Total cases (n 76) 33 43
SF-36 score (mean  SD)
Pre-op
Crude 66.2  21.1 61.0  17.7 .283
Age-adjusted 67.9  19.9 59.7  20.1 .112
Post-op 1 week
Crude 50.3  19.4 43.3  20.6 .196
Age-adjusted 52.2  20.4 41.6  20.6 .064
Post-op 1 month
Crude 48.0  16.1 49.9  20.7 .711
Age-adjusted 49.8  18.9 48.0  19.0 .756
Post-op 6 months:
Crude 72.3  19.8 58.7  19.4 .009
Age-adjusted 73.1  20.3 57.9  20.6 .007
SF-36, Medical Outcomes Study Short-Form 36-item survey.
*P values are based on Student’s t test for crude results and on analysis of
variance for age-adjusted results.betw
EV
6 (1
3 (7
1 (2
16 (2
2 (4
16 (4
24 (6
8 (1
3 (5the last decade with the introduction of endovascular tech-
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the reported advantages of EVAR are lower perioperative
morbidity and mortality, shorter hospital stay, lower blood
loss, and faster recovery.1,2 On the other hand, EVAR
demonstrated disadvantages, including the need for con-
tinuous postoperative surveillance, a higher reintervention
rate, and endoleak in up to 20% of patients.11-14 Because
EVAR is considerably less invasive than OR, intuitively, it
should be less likely to impact negatively on patient quality
of life in the postoperative period.
In this nonrandomized prospective cohort study, we
examined the longitudinal changes in quality of life re-
ported by patients undergoing elective EVAR or OR. Anal-
ysis of the data revealed that patients report significant
deterioration in quality of life in the early postoperative
period regardless of the type of procedure. We found
significant drops in mean scores in six of the eight domains
OPEN
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Fig 1. Change over time in mean Medical Outcomes Study
Short-Form 36-item (SF-36) health survey scores within each
domain for endovascular aneurysm repair (EVAR) and open repair
(Open) patients. The x axis indicates domain of the SF-36. PF,
Physical function; SF, social function; RP, role physical; RE, role
emotional; MH, mental health; VT, vitality; BP, bodily pain; GH,
general health. The y axis displays the mean SF-36 scores. Results
displayed using the same format as Prinssen et al.7of the SF-36 in OR patients and in five of the eight domainsin EVAR patients in the postoperative period. Quality of
life scores had returned to preoperative values in both
groups by 6 months after the procedure. In three domains,
vitality, physical function, and role emotional, the postop-
erative drop in mean scores was evident for longer in the
OR patients. This longer short-term drop in mean scores
might be a reflection of the less invasive EVAR procedure.
In this study, we clearly documented a less invasive, shorter,
and less complicated hospital stay in the EVAR patients.
Quality of life assessment tools such as the SF-36 can
help surgeons evaluate a patient’s perception of his or her
health and well being before and after surgery.15,16 The
standardized SF-36 health survey is a valuable instrument
to measure patient-perceived quality of life owing to its
high validity, reliability, psychometric propriety.17,18 In
addition, the ease with which it can be self-administered
removes third-party bias. The American College of Sur-
geons and the American Society of Vascular surgery have
both promoted the use of SF-36 in the surgical popula-
tion,18,19 and the SF-36 has been validated for patients
with vascular diseases.20
Our study has weaknesses. The small sample size and
the fact that treatment type was not assigned randomly in
these patients introduced the potential for bias. During
the study period, EVAR was selectively used at our
institution in patients who were considered high risk for
open surgical repair because of medical comorbidity but
who had suitable anatomy for EVAR. Although most of
the preoperative characteristics were comparable be-
tween the two patient groups, the EVAR patients were
older and had a significantly higher incidence of cancer.
This older population might be expected to score lower
than a younger and healthier population. The possibility
of a type II error also exists (wrongfully concluding to
accept the null hypothesis) because of the small sample
size and heterogeneity of both groups.
Other nonrandomized studies comparing quality of life
after EVAR and OR have not demonstrated any difference
in scores between the two groups in the late postoperative
period 3 months.5-9 This significant difference in mean
SF-36 scores between the two groups at 6 months might be
because this was not a randomized trial. At our institution,
patients were selectively treated by EVAR if they were
older, considered higher risk because of medical comorbid-
ity, or considered too frail to undergo OR. The possibility
of reintervention, failure of the endograft, and the uncer-
tainty about the long-term outcome might adversely affect
patient quality of life. However, when we reanalyzed our
results excluding patients who required readmission or
reoperation, or both, we found no significant difference in
the outcome of patient-reported quality of life scores. Clar-
ification of the reason for this finding will require further
evaluation.
The SF-36 results are displayed graphically for each of
its eight domains using the same format used in the Dutch
Randomized Endovascular Aneurysm trial7 (Fig 1). Inter-
estingly, the results of this randomized trial are nearly
identical to our results in a nonrandomized comparison. In
iance
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crease in scores in six of the eight domains of the SF-36
(with the exception of general health and mental health, as
in our study) in OR patients and in five of eight domains in
EVAR patients. They also reported faster recovery of mean
SF-36 scores to baseline in EVAR patients in the three
domains of social function, role emotional, and vitality. In
all domains of the SF-36, scores for the EVAR group
reached baseline values by 6 weeks postoperatively. Also, as
was found in our study, after 6 months the OR group
scored significantly higher than the EVAR.
Although one would not expect patients to feel physi-
cally better after full recovery from a procedure such as AAA
repair, higher SF-36 scores in the OR patients at 6 months
could be explained by a general feeling of physical or
psychologic well being after survival and recovery from a
treatment of a potentially life-threatening condition. Inter-
estingly, in their report and in others,5 mental health scores
continued to increase over time to reach significantly
higher scores than baseline in both groups, which the
authors felt might be explained by the relief of the anxiety
after the aneurysm repair.
Another prospective nonrandomized study6 that used
Table IV. Comparison of crude and age-adjusted SF-36 m
groups at preoperative and each of three follow-up time in
Subscale measure
Preoperative* Postoperative (
Open EVAR Open
1. Physical
function
Crude 59.2  7.2 52.4  4.4 37.6  28.7 39
Age-adjusted 58.5  27.0 53.0  29.6 37.7  29.1 39
2. Role physical
Crude 52.3  42.7 45.2  38.7 21.4  31.7 21
Age-adjusted 55.0  42.5 43.1  42.1 21.9  36.5 20
3. Bodily pain
Crude 74.6  24.7 69.9  27.0 57.3  34.9 43
Age-adjusted 78.1  26.6 67.3  26.6 60.2  34.3† 40
4. General
health
Crude 65.7  16.7 59.7  20.0 65.9  23.0† 50
Age-adjusted 67.9  19.0† 57.6  19.2† 67.9  23.8† 48
5. Vitality
Crude 58.3  22.6 50.4  20.3 45.2  24.0 43
Age-adjusted 60.4  21.9† 48.8  21.5† 47.0  25.9 41
6. Social
functioning
Crude 77.7  27.2 69.5  24.9 56.7  30.9 44
Age-adjusted 80.1  27.0 67.6  26.9 58.5  32.8 43
7. Role
emotional
Crude 72.9  39.2 63.5  42.8 42.9  43.4 40
Age-adjusted 73.7  43.6 63.3  43.4 42.4  45.0 41
8. Mental health
Crude 74.7  17.4 72.0  19.6 70.0  21.9 66
Age-adjusted 75.5  19.5 71.4  19.7 71.3  22.2 65
SF-36, Medical Outcomes Study Short-Form 36-item survey.
Data are shown as mean  standard deviation.
†Indicates statistically significant (P  .05) difference in mean score betwe
p-values are based on Student t-Test for crude results and on analysis of varthe SF-36 to compare postoperative quality of life after ORand EVAR reported a significant decline in the four do-
mains of physical function, social function, role physical,
and vitality after aneurysm repair in both OR and EVAR
patients. Mean scores for EVAR patients returned to base-
line in all domains by 4 weeks, and the OR group scores
returned to baseline by 8 weeks. The main difference in this
study compared with ours is that the preoperative mean
SF-36 baseline scores were significantly higher than the
general US population, and this might explain fast recovery
in all domains. In this study, the questionnaires where
administered during office visits or by telephone interview,
which may have biased patients responses since the SF-36 is
designed to be self-administered.
The Nottingham Health Profile (NHP) has been used
in other studies to measure patient-perceived quality of life
after EVAR and OR.9 The authors found no significant
difference at any time between the OR and EVAR groups
for NHP scores in the postoperative period up to 3 months.
When the NHP and SF-36 were compared in patients with
lower limb ischemia, both were found to be equally respon-
sive to changes in physical activity and pain; however, the
SF-36 is more responsive to changes in social activity and
psychologic status.20 This may explain the negative find-
subscale scores between open and endovascular repair
ls
k)* Postoperative (1 month)* Postoperative (6 months)*
R Open EVAR Open EVAR
26.8 45.9  22.2 43.5  26.2 66.0  25.2† 49.9  27.6†
28.7 45.0  25.3 44.5  25.0 65.1  27.8† 50.6  28.0†
37.0 9.8  23.9 20.8  33.9 67.5  48.3† 41.9  42.1†
36.2 10.4  30.7 20.2  30.6 65.8  47.7 43.4  47.2
32.3 53.2  23.2 52.3  29.4 73.9  25.1 65.1  28.2
33.9† 55.3  26.8 50.0  27.0 74.6  28.4 64.5  27.8
23.1† 64.5  20.9 55.2  24.2 67.1  20.2† 56.2  20.7†
23.2† 66.0  23.2 53.6  23.4 68.7  21.2† 54.7  21.0†
19.8 40.5  19.0 45.1  23.6 61.0  19.2 50.6  22.7
22.4 42.7  21.4 42.6  21.3 62.8  21.7† 48.9  21.9†
31.1 53.8  29.6 48.1  30.4 81.9  21.1† 61.0  31.2†
32.7 54.8  31.2 47.0  31.2 83.9  27.8† 59.2  27.4†
42.1 46.4  49.1 60.3  43.2 81.1  39.8† 60.8  39.8†
44.7 47.6  48.7 59.0  49.0 80.4  42.2 61.4  42.0
21.3 72.0  19.8 68.0  20.4 75.6  21.1 72.9  20.4
22.4 73.3  20.8 66.5  20.8 77.4  21.7 71.3  21.3
en repair (Open) and endovascular repair (EVAR) group at time interval,
for age-adjusted results.ean
terva
1 wee
EVA
.8 
.6 
.2 
.8 
.2 
.8 
.7 
.9 
.0 
.4 
.7 
.1 
.6 
.0 
.5 
.5 
en opings in this study using the NHP instrument.
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The findings of this nonrandomized prospective study
show that patient-perceived quality of life after infrarenal
AAA repair is significantly impaired in the early postopera-
tive period but returns to baseline by 6 months in patients
treated with EVAR and OR. Patients undergoing EVAR
had significantly more rapid return to preoperative scores in
selected domains of the SF-36. Even though EVAR is
associated with a less invasive operative procedure, a more
favorable perioperative hospital course, and a lower post-
operative complication rate, patients undergoing EVAR
have lower QOL scores 6 months after surgery than do
patients undergo OR. Despite the limitations of this study,
this data can be used to help inform our patients in the
preoperative planning as part of the informed consent
process, which will allow patients to be better informed
about the recovery period and overall well-being.
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All cases (n  76) Mean  SD P*
Endovascular
Pre—op 50.4  20.3 —
1 week 43.0  19.8 .2579
1 month 45.1  23.6 .3467
6 months 50.6  22.7 .8767
Social functioning
Open
Pre-op 77.7  27.2 —
1 week 56.7  30.9 .0006
1 month 53.8  29.6 .0001
6 months 81.9  21.1 .3978
Endovascular
Pre-op 69.5  24.9 —
1 week 44.7  31.1 .0004
1 month 48.1  30.4 .0066
6 months 61.0  31.2 .1403
Role emotional
Open
Pre-op 72.9  39.2 —
1 week 42.9  43.4 .0001
1 month 46.4  49.1 .0098
6 months 81.1  39.8 .5171
Endovascular
Pre-op 63.5  42.8 —
1 week 40.6  42.1 .0301
1 month 60.3  43.2 .6553
6 months 60.8  39.8 .7778
Mental health
Open
Pre-op 74.7  17.4 —
1 week 70.0  21.9 .0694
1 month 72.0  19.8 .2611
6 months 75.6  21.1 .7362
Endovascular
Pre-op 72.0  19.6 —
1 week 66.5  21.3 .1842
1 month 68.0  20.4 .4365
6 months 72.9  20.4 .6681
SF-36, Medical Outcomes Study Short-Form 36-item survey.
*The P values are based on paired Student’s t test statistics between baseline
and corresponding follow-up period.Table V (online only). Comparison statistics between
baseline SF-36 mean values and each of three follow up
intervals for open and endovascular repair procedures
All cases (n  76) Mean  SD P*
Total SF-36 measure
Open repair
Pre-op 66.2  21.1 —
1 week 50.3  19.4 .0001
1 month 48.0  16.1 .0001
6 months 72.3  19.8 .3084
Endovascular
Pre-op 61.0  17.7 —
1 week 43.3  20.6 .0005
1 month 49.9  20.7 .0208
6 months 58.7  19.4 .6529
Eight subscale measures
Physical function
Open
Pre-op 59.2  27.2 —
1 week 37.6  28.7 .0004
1 month 45.9  22.2 .0058
6 months 66.0  25.2 .1573
Endovascular
Pre-op 52.4  24.4 —
1 week 39.8  26.8 .0263
1 month 43.5  26.2 .0689
6 months 49.9  27.6 .5457
Role physical
Open
Pre-op 52.3  42.1 —
1 week 21.4  31.7 .0001
1 month 9.8  23.9 .0001
6 months 67.5  48.3 .2693
Endovascular
Pre-op 45.2  38.7 —
1 week 21.2  37.0 .0092
1month 20.8  33.9 .0031
6 months 41.9  42.1 .9146
Bodily pain
Open
Pre-op 74.6  24.7 —
1 week 57.3  34.9 .0035
1month 53.2  23.2 .0001
6 months 73.9  25.1 .8252
Endovascular
Pre-op 69.9  27.0 —
1 week 43.2  32.3 .0001
1 month 52.3  29.4 .0503
6 months 65.1  28.2 .8565
General health
Open
Pre-op 65.7  16.7 —
1 week 65.9  23.0 .6536
1 month 64.5  20.9 .3329
6 months 67.1  20.2 .3743
Endovascular
Pre-op 59.7  20.0 —
1 week 50.7  23.1 .1775
1 month 55.2  24.2 .2619
6 months 56.2  20.7 .4131
Vitality
Open
Pre-op 58.3  22.6 —
1 week 45.2  24.0 .0022
1 month 40.5  19.0 .0001
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Baseline 1 week 1 month 6 months
General
SF-36 66 50 47 53
Response rate (%) 86.8% 65.8% 61.8% 69.7%
Two main components
PHS 71 56 52 59
MHS 68 53 53 55
Eight subcomponents
PF 74 60 55 63
RP 75 60 54 63
BP 74 59 56 64
GH 74 59 56 63
VT 70 56 53 60
SF 76 61 57 65
RE 74 58 53 62
MH 76 61 57 66
N 76 61 57 66
Participation rate (%) 100 80.3 75.0 86.8
Number (Min-Max) 70-76 58-61 53-57 60-66
Response rate (%) (Min-Max)* 92.1-100.0 76.3-80.3 69.7-75.0 78.9-86.8
SF-36, Medical Outcomes Study Short-Form 36-item survey; PHS, physical health summary; MHS, mental health summary; PF, physical function; RP, role
physical; BP, bodily pain; GH, general health; VT, vitality; SF, social function; RE, role emotional; MH, mental health.
Note: Response rate is calculated by dividing number of responses by 76 (total number of participants at baseline) relative to baseline.
